Healthcare budget
The Centre on Friday approved Bharat Biotech’s needle-free intranasal Covid vaccine for booster dose, said an official source.
The nassal vaccine has been approved for those aged above 18 years. The vaccine will be available in the private hospitals for booster dose in the initial phase.
The source said that Nasal vaccine will be used as a heterologous booster among eligible population. Meanwhile, the intranasal Covid vaccine is also expected to be introduced in the COVID19 vaccination program from today, said the source.
The nasal vaccine is likely to be added to the CoWIN App from today.
Meanwhile, India on Friday reported 163 fresh COVID-19 cases along with 9 deaths have also been reported in the country. The number of active coronavirus cases declines to 3,380.
The Uttarakhand government has initiated major action against Baba Ramdev in light of misleading advertisements…
For the first time post Covid period, the Covishield vaccine maker AstraZeneca has admitted that…
A new study from healthcare provider Pristyn Care found that 5 out of 10 patients…
The Foreign Medical Students has protested against the National Medical Commission over a 3-year period…
WHO South-East Asia Region (SEAR) faces a disproportionately high burden of work-related mortality, with 36.5…
Cervical cancer is a culturally sensitive disease given its transmission through the sexual route and…